Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma V Atkinson, A Khattak, A Haydon, M Eastgate, A Roy, P Prithviraj, ... Journal for immunotherapy of cancer 8 (2), 2020 | 84 | 2020 |
Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma A Lepletier, J Madore, JS O'Donnell, RL Johnston, XY Li, E McDonald, ... Clinical cancer research 26 (14), 3671-3681, 2020 | 76 | 2020 |
The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial A Molassiotis, T Brown, HL Cheng, A Byrnes, RJ Chan, D Wyld, ... Nutrition journal 20, 1-15, 2021 | 28 | 2021 |
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non‐contrast CT scanning on the management of operable pancreatic and peri … ME Burge, N O'Rourke, D Cavallucci, R Bryant, A Francesconi, K Houston, ... HPB 17 (7), 624-631, 2015 | 28 | 2015 |
Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial P Mollee, S Okano, E Abro, D Looke, G Kennedy, J Harper, J Clouston, ... Journal of Hospital Infection 106 (2), 335-342, 2020 | 15 | 2020 |
Pushing the accelerator and releasing the brake: A phase I dose escalation study evaluating a LAG-3 fusion protein (eftilagimod alpha), together with pembrolizumab in … MA Eastgate, V Atkinson, MA Khattak, AC Roy, AM Haydon, C Mueller, ... Journal of Clinical Oncology 36 (15_suppl), e15099-e15099, 2018 | 14 | 2018 |
Using a Delphi process to determine optimal care for patients with pancreatic cancer EA Burmeister, SJ Jordan, DL O'Connell, VL Beesley, D Goldstein, ... Asia‐Pacific Journal of Clinical Oncology 12 (2), 105-114, 2016 | 14 | 2016 |
Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling intervention VL Beesley, J Turner, RJ Chan, P Yates, LG Gordon, M Burge, ... European Journal of Oncology Nursing 46, 101729, 2020 | 12 | 2020 |
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study A Kuchel, E Ahern, S Collins, V Whitehall, S Okano, A Pelecanos, D Wyld, ... Asia‐Pacific Journal of Clinical Oncology 17 (1), 84-93, 2021 | 9 | 2021 |
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in … J Dunn, RD McCuaig, AHY Tan, WJ Tu, F Wu, KM Wagstaff, A Zafar, S Ali, ... Cancers 14 (6), 1596, 2022 | 8 | 2022 |
Previous Bevacizumab and Efficacy of Later Anti–Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry M Burge, C Semira, B Lee, M Lee, S Kosmider, R Wong, J Shapiro, B Ma, ... Clinical Colorectal Cancer 17 (3), e593-e599, 2018 | 8 | 2018 |
Dietary patterns and attitudes in cancer patients. SF Lee, D Wyld, T Brown, MA Eastgate Journal of Clinical Oncology 36 (15_suppl), e22055-e22055, 2018 | 6 | 2018 |
Metastatic colorectal cancer during pregnancy: A tertiary center experience and review of the literature SF Lee, M Burge, M Eastgate Obstetric Medicine 12 (1), 38-41, 2019 | 5 | 2019 |
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis S Pathmanathan, H Babu, M Dzienis, M Azer, M Eastgate Pigment Cell & Melanoma Research 35 (6), 587-594, 2022 | 3 | 2022 |
Catheter-associated bloodstream infection in patients with cancer: comparison of left-and right-sided insertions M Jones, S Okano, D Looke, G Kennedy, G Pavilion, J Clouston, ... Journal of Hospital Infection 118, 70-76, 2021 | 3 | 2021 |
Health service resource use and costs of interventional oncology procedures: a micro-costing analysis SJ Senanayake, Q Xia, D Brain, S McPhail, S Kularatna, W Parsonage, ... OSF, 2023 | 1 | 2023 |
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma PKH Lau, SJ Harris, MA Eastgate, D Kee, A Mant, LM Nott, C Gedye, ... Journal of Clinical Oncology 41 (16_suppl), 9525-9525, 2023 | 1 | 2023 |
Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study E Ahern, P Thomas, L Campbell, M Latter, M Eastgate, D Wyld, DA Clark, ... | 1 | 2022 |
Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia H Gasper, E Ahern, N Roberts, B Chan, B Hughes, G Kennedy, D Wyld, ... BMJ open 11 (5), e044655, 2021 | 1 | 2021 |
Surgical series of metastatic cerebral melanoma: clinical association of resection, BRAF-mutation status, and survival S Colditz, M.J., Lee, S.F., Eastgate, M., Elder, S., Brandis, P., Anderson ... Interdisciplinary Neurosurgery, 2020 | 1* | 2020 |